Materiali

Slide kit

Giulia Marchetti

COVID-19 from immunepathogenesis to therapy

Matteo Augello

Immune responses to SARS-CoV-2 natural infection and vaccination in people

Tomaso Beringheli

Efficacy and virological clearance of antivirals/monoclonals in high-risk patients

Matteo Sala

Prevalence, phenotypes and predictive factors of PASC in the Eucare cohort

Roberta Rovito

Immunepathogenesis of PASC

Roberta Rovito

Microbiome Immunity and Diet in the development of pASC: MIDAS study

Camilla Tincati

The gut as a site of immunepathogenesis

Valeria Bono

Effects of cART on residual inflammation and HIV reservoirs in Primary and Chronic HIV infection

Camilla Falcinella

Study of the gastrointestinal tract in acute HIV infection

Riccardo Nardo

New antiretrovirals for HIV: real-life experience with doravirine

Daniele Tomasoni

Switching to Long-Acting Injectable Antiretroviral Therapy: experience from our Clinic

Matteo Sala

HBcAb positivity on two-drug regimens in SPID: evidence of HBV reactivation?

Andrea Santoro

High Prevalence of HIV Infection and Late Diagnoses by HIV indicator conditions guided screening in the Emergency Department: preliminary results from INDI study

Lorenzo Biasioli

Sexually Transmitted Infections In A Northern Italy Sti Clinic: results of the SECS study

community based setting. Sexually Transmitted Infections - Epidemiology in a Clinical Setting

/assets/17-10-Tesoro.pdf

Alessandro Tavelli

Patient-related outcomes (PROs)

Francesca Bai

Long-acting and Outpatient Parenteral Antimicrobial Therapy (OPAT): challenges and opportunities

Roberto Castoldi

Superinfections in patients on invasive and non-invasive ventilation during Covid-19: prevalence, predictive factors and mortality

Tomaso Beringheli

Predictors of treatment choice in the management of ABSSSIs (Dalbavancin versus SoC)

Francesco Mola'

Factors associated with persistent Gram-positive bacteremia

Lorenzo Albertini

Switch from intravenous to oral antibiotic therapy in the treatment of infective endocarditis: preliminary results and PDTA proposal

Benedetta Varisco

CEFI-BAC Study: A Multicentre Observational Study on Cefiderocol for the Treatment of Multi-Drug Resistant Gram-Negative Bacteria (Ongoing Research Update).

Roberto Castoldi

Proposal for the implementation of infection prevention and control (IPC) e dell’ antimicrobial stewardship (AMD).